Alzheimer's Disease and Related Tau Disorders

Image 1

Our Research

The Vossel Laboratory studies mechanisms and novel treatments for epileptic activity and associated memory loss in Alzheimer’s disease. Investigations include cell and molecular, neural network, and behavior relationships in mouse models of Alzheimer’s disease and related dementias, and bridges bench discoveries with human clinical trials.

Image 2

News

Listen to Dr. Keith Vossel's interview with Kevin McCullough, New York's "Radio Night Live" AM970, on July 13, 2022, discussing the causes and risk factors of Alzheimer's disease and the work of the Easton Center in conducting clinical trials and research to find treatments.

Part 1:
https://eastonad.ucla.edu/images/media/Dr_Vossel_Pt-1_RNL_WNYM_Seg-2_7-13-22.mp3

Part 2:
https://eastonad.ucla.edu/images/media/Dr_Vossel_Pt-2_RNL_WNYM_Seg-3_7-13-22.mp3

Part 3:
https://eastonad.ucla.edu/images/media/Dr_Vossel_Pt-3_RNL_WNYM_Seg-4_7-13-22.mp3

Dr. Keith Vossel's exclusive interview with Alex Cohen about Alzheimer’s and Brain Awareness Month aired on Tues, June 28, 2022, around 8:40 PM, Spectrum News 1 SoCal Inside the Issues.
@SpecNews1SoCal, #BrainAwareness

Dr. Vossel's Op-Ed in the L.A. Times: Did aphasia influence Bruce Willis’ career decisions? Every case is unique

Dr. Vossel was interviewed for USA Today article, “Report: Up to 18% of adults over 60 have early stages of memory loss, cognitive problems.”

Dr. Vossel's Op-Ed in the L.A. Times: The first treatment for Alzheimer's taught us some hard lessons

Phase 2a clinical trial published in JAMA Neurology. Low doses of an inexpensive and widely available antiseizure drug improves learning and memory and executive function in AD patients with epileptic activity
Links: